FCN1 and acute myeloid leukemia: Moreover, metabolic pathways, including Glycosphingolipid biosynthesis and degradation, Tryptophan metabolism, and Arachidonic acid metabolism, are activated in the FCN1 high-expression group across multiple cancers such as BRCA, COAD, AML, and LUAD.